Clinical Trial Update: Endostar Combine With Radiotherapy in Brain Metastasis of NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial exploring Endostar combined with radiotherapy for brain metastases stemming from non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Endostar (recombinant human endostatin)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN